Brighton Jones LLC trimmed its position in shares of The Allstate Co. (NYSE:ALL – Free Report) by 1.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,057 shares of the insurance provider’s stock after selling 75 shares during the quarter. Brighton Jones LLC’s holdings in Allstate were worth $769,000 as of its most recent SEC filing.
A number of other hedge funds have also recently made changes to their positions in ALL. Northwest Investment Counselors LLC acquired a new position in shares of Allstate in the third quarter worth approximately $28,000. Versant Capital Management Inc lifted its stake in shares of Allstate by 70.9% in the second quarter. Versant Capital Management Inc now owns 188 shares of the insurance provider’s stock worth $30,000 after acquiring an additional 78 shares during the period. Family Firm Inc. acquired a new position in shares of Allstate in the second quarter worth approximately $38,000. MCF Advisors LLC increased its holdings in Allstate by 33.9% in the second quarter. MCF Advisors LLC now owns 332 shares of the insurance provider’s stock worth $53,000 after purchasing an additional 84 shares in the last quarter. Finally, Sunbelt Securities Inc. increased its holdings in Allstate by 38.5% in the first quarter. Sunbelt Securities Inc. now owns 363 shares of the insurance provider’s stock worth $63,000 after purchasing an additional 101 shares in the last quarter. 76.47% of the stock is owned by institutional investors and hedge funds.
Allstate Stock Performance
NYSE:ALL opened at $188.12 on Friday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.36 and a current ratio of 0.36. The Allstate Co. has a 52-week low of $122.53 and a 52-week high of $198.79. The firm has a market cap of $49.65 billion, a price-to-earnings ratio of 41.53, a PEG ratio of 1.74 and a beta of 0.48. The business’s fifty day moving average is $188.01 and its 200 day moving average is $174.36.
Insider Activity at Allstate
In related news, CEO Thomas J. Wilson sold 90,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at $15,880,915.68. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, CEO Thomas J. Wilson sold 90,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $179.34, for a total transaction of $16,140,600.00. Following the transaction, the chief executive officer now directly owns 88,552 shares in the company, valued at $15,880,915.68. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Elizabeth Brady sold 49,481 shares of the firm’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $179.09, for a total value of $8,861,552.29. Following the transaction, the executive vice president now owns 19,163 shares in the company, valued at approximately $3,431,901.67. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 192,530 shares of company stock valued at $34,967,665. Corporate insiders own 1.80% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have weighed in on ALL shares. BMO Capital Markets lifted their target price on Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. Barclays began coverage on Allstate in a report on Wednesday, September 4th. They set an “underweight” rating and a $175.00 price objective for the company. Wells Fargo & Company decreased their price objective on Allstate from $177.00 to $175.00 and set an “equal weight” rating for the company in a report on Friday, August 16th. Evercore ISI boosted their price objective on Allstate from $191.00 to $195.00 and gave the company an “in-line” rating in a report on Wednesday, October 9th. Finally, Roth Mkm restated a “buy” rating and set a $200.00 price objective on shares of Allstate in a report on Wednesday, August 14th. One research analyst has rated the stock with a sell rating, two have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $206.44.
Read Our Latest Research Report on ALL
Allstate Company Profile
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Recommended Stories
- Five stocks we like better than Allstate
- The How and Why of Investing in Gold Stocks
- Texas Roadhouse Stock Steering for New Highs This Year
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Monopar Therapeutics Skyrockets 400% on Licensing Deal
- What is a SEC Filing?
- Tractor Supply Stock Pulls Back: A Prime Buying Opportunity
Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.